Literature DB >> 18801874

Daily symptom burden in end-stage chronic organ failure: a systematic review.

D J A Janssen1, M A Spruit, E F M Wouters, J M G A Schols.   

Abstract

Chronic diseases are nowadays the major cause of morbidity and mortality worldwide. Patients with end-stage chronic organ failure may suffer daily from distressful physical and psychological symptoms. The objective of the present study is to systematically review studies that examined daily symptom prevalence in patients with end-stage chronic organ failure, with attention to those that included patients with either congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or chronic renal failure (CRF). Thirty-nine articles (8 CHF, 7 COPD, 2 CHF and COPD, 22 CRF) have been included. The included studies used various study designs. There was a wide range of daily symptom prevalence that may be due to the heterogeneity in methodology used. Nevertheless, findings suggest significant symptom burden in these patients. This review highlights the need for further prospective and longitudinal research on symptom prevalence in patients with end-stage CHF, COPD and CRF to facilitate the development of patient-centred palliative care programs.

Entities:  

Mesh:

Year:  2008        PMID: 18801874     DOI: 10.1177/0269216308096906

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  38 in total

Review 1.  Drug therapy optimization at the end of life.

Authors:  Alfonso J Cruz-Jentoft; Benoit Boland; Lourdes Rexach
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Prevalence of symptoms at the end of life in an acute care hospital: a retrospective cohort study.

Authors:  Daniel Kobewka; Paul Ronksley; Dan McIsaac; Sunita Mulpuru; Alan Forster
Journal:  CMAJ Open       Date:  2017-03-09

3.  Disparities in symptom burden and renal transplant eligibility: a pilot study.

Authors:  Nathaniel Berman; Kaylan Christianer; Jordan Roberts; Rachel Feldman; M Cary Reid; Rouzi Shengelia; Jeanne Teresi; Joseph Eimicke; Brian Eiss; Ronald Adelman
Journal:  J Palliat Med       Date:  2013-10-10       Impact factor: 2.947

4.  [Tools for optimizing pharmacotherapy for geriatric patients with multimorbidity at the end of life: helpful oder just raising awareness?].

Authors:  Renate Riesinger; Bernhard Iglseder
Journal:  Wien Med Wochenschr       Date:  2014-04-09

Review 5.  Palliative and end-of-life care issues in chronic kidney disease.

Authors:  Sara A Combs; Sara N Davison
Journal:  Curr Opin Support Palliat Care       Date:  2015-03       Impact factor: 2.302

6.  Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.

Authors:  Panaiotis Finamore; Martijn A Spruit; Jos M G A Schols; Raffaele Antonelli Incalzi; Emiel F M Wouters; Daisy J A Janssen
Journal:  Aging Clin Exp Res       Date:  2020-04-11       Impact factor: 3.636

7.  Improving symptom management in hemodialysis patients: identifying barriers and future directions.

Authors:  Rachel Feldman; Nathaniel Berman; M Cary Reid; Jordan Roberts; Rouzi Shengelia; Kaylan Christianer; Brian Eiss; Ronald D Adelman
Journal:  J Palliat Med       Date:  2013-12       Impact factor: 2.947

8.  Provision of palliative care for chronic heart failure inpatients: how much do we need?

Authors:  Richard Harding; Teresa Beynon; Fiona Hodson; Elaine Coady; Mark Kinirons; Lucy Selman; Irene Higginson
Journal:  BMC Palliat Care       Date:  2009-06-29       Impact factor: 3.234

Review 9.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

10.  A zebrafish model for uremic toxicity: role of the complement pathway.

Authors:  Nathaniel Berman; Melisa Lectura; Josh Thurman; James Reinecke; Amanda C Raff; Michal L Melamed; James Reinecke; Zhe Quan; Todd Evans; Timothy W Meyer; Thomas H Hostetter
Journal:  Blood Purif       Date:  2013-05-08       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.